| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $21,780,567 ) (Continued on the next page) |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | UM1AI069439 | Vanderbilt HIV Clinical Trials Unit (CTU) | 000 | 19 | NIH | 11/8/2023 | $329,390 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | K00CA253718 | Deciphering molecular mechanisms of Epithelial Plasticity | 000 | 5 | NIH | 11/14/2023 | $97,217 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01DK131070 | The Origins of Human Anti-Insulin B Lymphocytes in Type 1 Diabetes | 000 | 3 | NIH | 11/28/2023 | $386,349 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | F32DC020347 | Optimizing cochlear implants for music perception | 000 | 3 | NIH | 11/17/2023 | $73,772 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R33MH122464 | Nicotinic Modulation of the Cognitive Control System in Late-Life Depression | 000 | 4 | NIH | 11/10/2023 | $878,915 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R21MH132040 | Development of brain structure supporting face learning in infants at risk for autism | 000 | 2 | NIH | 11/9/2023 | $198,013 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | D43TW011544 | Vanderbilt-Nigeria Building Research Capacity in HIV and Non-communicable Diseases (NCDs) (V-BRCH) | 000 | 5 | NIH | 11/17/2023 | $277,162 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | D43TW011544 | Vanderbilt-Nigeria Building Research Capacity in HIV and Non-communicable Diseases (NCDs) (V-BRCH) | 000 | 5 | NIH | 11/17/2023 | $25,000 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R13DC020098 | Annual Meeting of the Population Hearing Health Care (PopHHC) Network | 000 | 3 | NIH | 11/28/2023 | $38,342 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01DC017926 | Language Processing in Context Following Traumatic Brain Injury | 000 | 5 | NIH | 11/7/2023 | $582,188 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | OT2OD035404 | All of Us Research Program Data and Research Center | 000 | 1 | NIH | 11/10/2023 | $12,400,000 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | K23MH122737 | Emotion Regulation Flexibility and Suicide Risk | 000 | 4 | NIH | 10/26/2023 | $169,617 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01CA237895 | Time-dependent and bidirectional effect of oxidative stress - a missing piece of the free radical theory of cancer and its potential implications | 000 | 5 | NIH | 11/30/2023 | $615,943 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | K23DK131341 | Precision Medicine Approaches for Eosinophilic Esophagitis Using Raman Spectroscopy and Machine Learning | 000 | 3 | NIH | 11/28/2023 | $172,637 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01MH121620 | 1/3-Recurrence Markers, Cognitive Burden and Neurobiological Homeostasis in Late-life Depression (Rembrandt) | 000 | 5 | NIH | 11/29/2023 | $720,394 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01MH121455 | Distinguishing Clinical and Genetic Risk of Suicidal Ideation from Attempts to Inform Prevention | 000 | 5 | NIH | 10/25/2023 | $489,362 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01AI180038 | Human M Cells Require Coronin 1a | 000 | 1 | NIH | 11/17/2023 | $635,744 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01HL161095 | Hemodynamic Effects of Positive Airway Pressure to Treat Supine Hypertension and Improve Neurogenic Orthostatic Hypotension | 000 | 3 | NIH | 11/14/2023 | $606,467 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01AI155668 | Comprehensive antigenic mapping of the human anti-peanut IgE antibody response | 000 | 4 | NIH | 11/21/2023 | $715,663 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | K23AI156132 | Immune, Microbial, and Metabolic Factors that Impact Clostridioides difficile and Inflammatory Bowel Disease in Children | 000 | 4 | NIH | 10/31/2023 | $175,716 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01GM139891 | PheMAP: Measured, Automated Profile to Facilitate High Throughput Phenotyping | 000 | 4 | NIH | 11/21/2023 | $389,250 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01AI141448 | Cell Intrinsic Immune Control of KSHV | 000 | 5 | NIH | 11/14/2023 | $382,122 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | UM1AI148452 | Vanderbilt Vaccine and Treatment Evaluation Unit | 001 | 5 | NIH | 11/8/2023 | $370,546 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | UM1AI148452 | Vanderbilt Vaccine and Treatment Evaluation Unit | 001 | 5 | NIH | 11/8/2023 | $607,495 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01ES031401 | Manganese exposure susceptibility as a modifier of excitotoxicity in Alzheimer's Disease | 000 | 5 | NIH | 10/23/2023 | $535,556 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | UM1AI069439 | Vanderbilt HIV Clinical Trials Unit (CTU) | 000 | 19 | NIH | 11/8/2023 | $995,361 |
| | 2024 | 2023 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | U01AI155299 | Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-Related, Symptomatic Asthma | 000 | 3 | NIH | 11/30/2023 | $0 |
| | 2024 | 2023 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01EY031315 | Ocular Inflammatory Mediators in the Pathophysiology of Diabetic Retinopathy | 000 | 4 | NIH | 10/16/2023 | $0 |
| | 2024 | 2023 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R56HL166941 | Defining the biologic and physiologic trajectory of presymptomatic through advanced pulmonary fibrosis | 000 | 1 | NIH | 10/17/2023 | $0 |
| | 2024 | 2023 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01EY024997 | Mechanisms of Adaptive Remodeling and Their Therapeutic Potential in Glaucoma | 000 | 7 | NIH | 10/16/2023 | $0 |
| | 2024 | 2023 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01AG085287 | Reducing Perioperative Oxidative Stress to Prevent Postoperative Chronic Pain Following Total Knee Arthroplasty | 000 | 1 | NIH | 10/24/2023 | $0 |
| | 2024 | 2023 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01AG065249 | Early Cognitive Training and Rehabilitation to Prevent Cognitive Decline in Older Hospitalized Adults with Delirium | 002 | 3 | NIH | 11/21/2023 | $0 |
| | 2024 | 2023 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | K01AG073587 | Attentional Mechanisms of Cognitive Compensation in Subjective Cognitive Decline and AD Risk | 000 | 1 | NIH | 10/17/2023 | $0 |
| | 2024 | 2023 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01AG065249 | Early Cognitive Training and Rehabilitation to Prevent Cognitive Decline in Older Hospitalized Adults with Delirium | 000 | 3 | NIH | 10/13/2023 | $0 |
| | 2024 | 2023 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | P50MD017347 | Southeast Collaborative for Innovative and Equitable Solutions to Chronic Disease Disparities | 001 | 3 | NIH | 11/7/2023 | $0 |
| | 2024 | 2023 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | F32AI157215 | Defining the molecular inventory of staphylococcal tissue abscesses and its effects on the host-pathogen interface | 000 | 3 | NIH | 11/16/2023 | -$46,863 |
| | 2024 | 2023 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | P50MD017347 | Southeast Collaborative for Innovative and Equitable Solutions to Chronic Disease Disparities | 000 | 3 | NIH | 10/10/2023 | $0 |
| | 2024 | 2023 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R21AR080233 | The Malate-Aspartate shuttle links dietary fatty acids to inflammatory responses in dendritic cells | 000 | 2 | NIH | 11/17/2023 | $0 |
| | 2024 | 2023 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | H4B30752 | Poison Control Stabilization and Enhancement Program | 01 | 8 | HRSA | 10/20/2023 | $0 |
| | 2024 | 2023 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01DC020888 | Consequences of chronic noise exposure in nonhuman primates | 000 | 1 | NIH | 10/12/2023 | $0 |
| | 2024 | 2023 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | U2CCA233291 | Integrative Single-Cell Atlas of Host and Microenvironment in Colorectal Neoplastic Transformation | 000 | 1 | NIH | 10/26/2023 | $0 |
| | 2024 | 2023 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01CA214494 | Molecular Complete Response in Blood as a Predictor for a Pathologic Complete Response after Neoadjuvant Therapy fo Breast Cancer | 000 | 6 | NIH | 11/8/2023 | $0 |
| | 2024 | 2023 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | U01HG011166 | Invitae Supplement: eMERGE Risk Assessment Network Coordinating Center | 000 | 4 | NIH | 11/27/2023 | $0 |
| | 2024 | 2023 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01CA077955 | H. Pylori Relationship to Digestive Diseases and Cancer | 000 | 27 | NIH | 10/25/2023 | $0 |
| | 2024 | 2023 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | U01CA254832 | IMProving Care After Inherited Cancer Testing (IMPACT) Study | 000 | 4 | NIH | 10/31/2023 | $0 |
| | 2024 | 2023 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | U01CA232829 | Improving identification and healthcare for patients with Inherited Cancer Syndromes: Evidence-based EMR implementation using a web-based computer platform | 000 | 1 | NIH | 11/15/2023 | $0 |
| | 2024 | 2023 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | U01CA152662 | Clinical Utility of a Combined Biomarker Approach to Diagnose Lung Cancer | 000 | 12 | NIH | 11/8/2023 | $0 |
| | 2024 | 2023 | Vanderbilt University Medical Center | 1161 21st Ave S Ste D3300 MCN | Nashville | TN | 37232-0011 | DAVIDSON | USA | NU3HCK000006 | Enhanced Detection of Resistance, Antibiotic Stewardship and infection control, and Genome sequencing NETwork for AMR containment (DRAGNET) | 01 | 3 | CDC | 11/9/2023 | $0 |
| | 2024 | 2023 | Vanderbilt University Medical Center | 1161 21st Ave S Ste D3300 MCN | Nashville | TN | 37232-0011 | DAVIDSON | USA | NU2GGH002367 | Avante | 02 | 3 | CDC | 11/14/2023 | $0 |
|
